Psoriasis is a chronic, immune-mediated skin condition. It causes red, scaly, itchy, often inflamed patches. Because the ...
With all that in mind, if you have $2,000 available to invest that isn't needed for monthly bills, to pay down short-term ...
The global psoriasis burden shows a slight increase from 1990 to 2021 and is projected to rise further by 2050.
Arcutis Biotherapeutics recently announced that the FDA has accepted its supplemental New Drug Application for ZORYVE cream 0.3% to treat plaque psoriasis in children aged 2 to 5 years, with a PDUFA ...
J&J's 16.7% rise reflects stronger sales guidance, rapid pipeline advances and improving MedTech momentum amid a recovering sector.
Arcutis aims to expand its market reach with new approvals. Management recently pleased the market with its sales guidance ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results